What We're Reading: Page 164
Industry reads hand-picked by our editors
May 07, 2021
-
The Financial Times
Angela Merkel rejects US move to waive patents on vaccines
-
The Wall Street Journal
Elizabeth Holmes Fights to Shield Wealth From Jury
-
MSNBC
Former FDA Commissioner talks return to normal life, says he will vaccinate his kids when eligible
-
Evaluate Vantage
At long last, tremelimumab scores
May 06, 2021
-
The Washington Post
Pfizer-BioNTech vaccine offers strong protection against key variants of concern, real-world data from Qatar shows
-
Evaluate Vantage
A surprise Keytruda approval, and what it means for biotech
-
Nature
Why some researchers oppose unrestricted sharing of coronavirus data
-
NPR
They Desperately Need COVID Vaccines. So Why Are Some Countries Throwing Out Doses?
May 05, 2021
May 04, 2021
-
The New York Times
F.D.A. Set to Authorize Pfizer Vaccine for Adolescents by Early Next Week
-
Reuters
Big three drug distributors blame doctors, regulators in trial over opioid epidemic
-
Science
What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest
-
Fierce Biotech
Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke
May 03, 2021
-
Fortune
GoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
-
NBC News
FDA wants 'significant' amount of extra data on AstraZeneca's Covid vaccine
-
STAT
With Amgen's KRAS cancer drug, worry about pricing, not safety
-
San Diego Union-Tribune
So coronavirus vaccines aren’t perfect. They’re still very, very effective
Apr 30, 2021
-
Bloomberg
Tens of Millions of J&J Doses Sit on Shelves Awaiting FDA Review
-
Financial Times
Vaccitech valued at $579M in US public offering
-
FierceBiotech
AstraZeneca drops BCMA drug after seeing early clinical data
-
The New York Times
They Call It a 'Women’s Disease.' She Wants to Redefine It.
Apr 29, 2021
-
STAT
Biden pitches a new health agency to help 'end cancer as we know it'
-
The Washington Post
Brazil rejects Russia’s Sputnik V coronavirus vaccine in blow to Moscow’s soft power efforts
-
Investor's Business Daily
Bristol Myers Stock Slides As Earnings, Sales Fall Short
-
Philadelphia Business Journal
Pfizer puts 340-acre Collegeville campus up for sale
Previous
